Aprea Therapeutics, Inc. (APRE)
R&D to Revenue
0.00%
Quarterly · Period ending:
APRE R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
APRE Quarterly R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
APRE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1,618.9965% | |
| 1,528.3886% | |
| 1,146.2056% | |
| 802.6595% | |
| 455.4483% | |
| 420.5211% | |
| 14,534.1954% | |
| 664.418% | |
| 882.1637% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |